{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:03:02Z","timestamp":1772114582556,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-21313-6","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T10:14:38Z","timestamp":1739182478000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends and projections of hypertensive heart disease burden in China: a comprehensive analysis from 1990 to 2030"],"prefix":"10.1186","volume":"25","author":[{"given":"Li-You","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"21313_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2017.05.013","volume":"122","author":"G Seravalle","year":"2017","unstructured":"Seravalle G, Grassi G. Obesity and hypertension. Pharmacol Res. 2017;122:1\u20137. https:\/\/doi.org\/10.1016\/j.phrs.2017.05.013. Epub 2017\/05\/24.","journal-title":"Pharmacol Res"},{"issue":"6","key":"21313_CR2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s11906-013-0386-8","volume":"15","author":"KM Diaz","year":"2013","unstructured":"Diaz KM, Shimbo D. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15(6):659\u201368. Epub 2013\/09\/21. doi: 10.1007\/s11906-013-0386-8. PubMed PMID: 24052212; PubMed Central PMCID: PMCPMC3901083.","journal-title":"Curr Hypertens Rep"},{"key":"21313_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.03.036","author":"JP Tripathy","year":"2017","unstructured":"Tripathy JP, Thakur JS, Jeet G, Jain S. Prevalence and determinants of comorbid diabetes and hypertension: Evidence from non communicable disease risk factor STEPS survey, India. Diabetes Metab Syndr. 2017;11. https:\/\/doi.org\/10.1016\/j.dsx.2017.03.036. Epub 2017\/04\/12. Suppl 1:S459-s65."},{"issue":"6","key":"21313_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1161\/circulationaha.115.018912","volume":"134","author":"KT Mills","year":"2016","unstructured":"Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: a systematic analysis of Population-Based studies from 90 countries. Circulation. 2016;134(6):441\u201350. https:\/\/doi.org\/10.1161\/circulationaha.115.018912. Epub 2016\/08\/10.","journal-title":"Circulation"},{"issue":"2a","key":"21313_CR5","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0002-9343(84)90955-0","volume":"76","author":"L Hansson","year":"1984","unstructured":"Hansson L, Lundin S. Hypertension and coronary heart disease: cause and consequence or associated diseases? Am J Med. 1984;76(2a):41\u20134. https:\/\/doi.org\/10.1016\/0002-9343(84)90955-0. Epub 1984\/02\/27.","journal-title":"Am J Med"},{"issue":"1","key":"21313_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/hypertensionaha.116.07418","volume":"68","author":"A Lother","year":"2016","unstructured":"Lother A, Hein L. Vascular mineralocorticoid receptors: linking risk factors, hypertension, and Heart Disease. Hypertension. 2016;68(1):6\u201310. https:\/\/doi.org\/10.1161\/hypertensionaha.116.07418. Epub 2016\/05\/25.","journal-title":"Hypertension"},{"issue":"10","key":"21313_CR7","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/cir.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 update: a Report from the American Heart Association. Circulation. 2019;139(10):e56\u2013528. https:\/\/doi.org\/10.1161\/cir.0000000000000659. Epub 2019\/02\/01.","journal-title":"Circulation"},{"issue":"1","key":"21313_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1161\/hypertensionaha.122.19373","volume":"80","author":"J D\u00edez","year":"2023","unstructured":"D\u00edez J, Butler J. Growing heart failure Burden of Hypertensive Heart Disease: a call to action. Hypertension. 2023;80(1):13\u201321. https:\/\/doi.org\/10.1161\/hypertensionaha.122.19373. Epub 2022\/09\/10.","journal-title":"Hypertension"},{"issue":"8","key":"21313_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to Heart failure: contemporary update. JACC Heart Fail. 2017;5(8):543\u201351. https:\/\/doi.org\/10.1016\/j.jchf.2017.04. Epub 2017\/07\/18.","journal-title":"JACC Heart Fail"},{"key":"21313_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.006","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE, Jr., Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;71(19):e127-e248. Epub 2017\/11\/18. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006. PubMed PMID: 29146535."},{"issue":"1","key":"21313_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.hfc.2019.09","volume":"16","author":"KE Di Palo","year":"2020","unstructured":"Di Palo KE, Barone NJ. Hypertension and heart failure: Prevention, targets, and treatment. Heart Fail Clin. 2020;16(1):99\u2013106. https:\/\/doi.org\/10.1016\/j.hfc.2019.09. Epub 2019\/11\/19.","journal-title":"Heart Fail Clin"},{"issue":"4","key":"21313_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","volume":"15","author":"J Slivnick","year":"2019","unstructured":"Slivnick J, Lampert BC. Hypertension and heart failure. Heart Fail Clin. 2019;15(4):531\u201341. https:\/\/doi.org\/10.1016\/j.hfc.2019.06.007. Epub 2019\/09\/02.","journal-title":"Heart Fail Clin"},{"issue":"1","key":"21313_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12889-022-13271-0","volume":"22","author":"Y Lu","year":"2022","unstructured":"Lu Y, Lan T. Global, regional, and national burden of hypertensive heart disease during 1990\u20132019: an analysis of the global burden of disease study 2019. BMC Public Health. 2022;22(1):841. https:\/\/doi.org\/10.1186\/s12889-022-13271-0. Epub 2022\/04\/28.","journal-title":"BMC Public Health"},{"issue":"2","key":"21313_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41371-021-00570-z","volume":"36","author":"R Yin","year":"2022","unstructured":"Yin R, Yin L, Li L, Silva-Nash J, Tan J, Pan Z, et al. Hypertension in China: burdens, guidelines and policy responses: a state-of-the-art review. J Hum Hypertens. 2022;36(2):126\u201334. https:\/\/doi.org\/10.1038\/s41371-021-00570-z. Epub 2021\/07\/04.","journal-title":"J Hum Hypertens"},{"issue":"4","key":"21313_CR15","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamainternmed.2016.0190","volume":"176","author":"S Lewington","year":"2016","unstructured":"Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, et al. The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. JAMA Intern Med. 2016;176(4):524\u201332. https:\/\/doi.org\/10.1001\/jamainternmed.2016.0190. Epub 2016\/03\/15.","journal-title":"JAMA Intern Med"},{"issue":"6","key":"21313_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.26599\/1671-5411.2023.06.001","volume":"20","author":"T In China","year":"2023","unstructured":"In China T, Hu SS. Report on cardiovascular health and diseases in China 2021: an updated summary. J Geriatric Cardiology: JGC. 2023;20(6):399\u2013430. https:\/\/doi.org\/10.26599\/1671-5411.2023.06.001. Epub 2023\/07\/07.","journal-title":"J Geriatric Cardiology: JGC"},{"key":"21313_CR17","doi-asserted-by":"publisher","first-page":"833345","DOI":"10.3389\/fpubh.2022.833345","volume":"10","author":"D Xu","year":"2022","unstructured":"Xu D, Hu J, Wang S, Chen L. Trends in the prevalence of Hypertensive Heart Disease in China from 1990 to 2019: a joinpoint and age-period-cohort analysis. Front Public Health. 2022;10:833345. https:\/\/doi.org\/10.3389\/fpubh.2022.833345. Epub 2022\/04\/05.","journal-title":"Front Public Health"},{"key":"21313_CR18","doi-asserted-by":"publisher","unstructured":"Peng W, Li K, Yan AF, Shi Z, Zhang J, Cheskin LJ, et al. Prevalence, management, and Associated Factors of Obesity, hypertension, and diabetes in Tibetan Population compared with China overall. Int J Environ Res Public Health. 2022;19(14). https:\/\/doi.org\/10.3390\/ijerph19148787. Epub 2022\/07\/28.","DOI":"10.3390\/ijerph19148787"},{"issue":"10204","key":"21313_CR19","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/s0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2019;394(10204):1145\u201358. https:\/\/doi.org\/10.1016\/s0140-6736(19)30427-1. Epub 2019\/06\/30.","journal-title":"Lancet"},{"key":"21313_CR20","doi-asserted-by":"publisher","unstructured":"Five insights from the Global Burden of Disease Study. 2019. Lancet. 2020;396(10258):1135-59. Epub 2020\/10\/19. https:\/\/doi.org\/10.1016\/s0140-6736(20)31404-5. PubMed PMID: 33069324; PubMed Central PMCID: PMCPMC7116361.","DOI":"10.1016\/s0140"},{"key":"21313_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30925-9","author":"Global burden of 369 diseases","year":"2020","unstructured":"Global burden of 369 diseases. Lancet. 2020;396(10258):1204\u201322. https:\/\/doi.org\/10.1016\/s0140-6736(20)30925-9. Epub 2020\/10\/19. and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019."},{"key":"21313_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32279-7","author":"regional Global","year":"2018","unstructured":"Global regional. national incidence, prevalence, and years lived with disability for 354 diseases and. Lancet. 2018;392(10159):1789\u2013858. https:\/\/doi.org\/10.1016\/s0140-6736(18)32279-7. Epub 2018\/11\/30. injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017."},{"key":"21313_CR23","doi-asserted-by":"publisher","unstructured":"Global regional. and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736-88. Epub 2018\/11\/30. https:\/\/doi.org\/10.1016\/s0140-6736(18)32203-7. PubMed PMID: 30496103; PubMed Central PMCID: PMCPMC6227606.","DOI":"10.1016\/s0140-6736(18)32203-7"},{"key":"21313_CR24","doi-asserted-by":"publisher","unstructured":"Karbasi M, Kolossa D. ASR-based speech intelligibility prediction: A review. Hear Res. 2022;426:108606. Epub 2022\/09\/27. https:\/\/doi.org\/10.1016\/j.heares.2022.108606. PubMed PMID: 36154977.","DOI":"10.1016\/j.heares.2022.108606"},{"issue":"2","key":"21313_CR25","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13(2):e58\u201368. 12)70040-2. PubMed PMID: 22300860.","journal-title":"Lancet Oncol"},{"issue":"11","key":"21313_CR26","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.Epi-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2296\u2013302. https:\/\/doi.org\/10.1158\/1055-9965.Epi-14-0300. Epub 2014\/08\/26.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"21313_CR27","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/bimj.201500263","volume":"59","author":"A Riebler","year":"2017","unstructured":"Riebler A, Held L. Projecting the future burden of cancer: bayesian age-period-cohort analysis with integrated nested Laplace approximations. Biom J. 2017;59(3):531\u201349. https:\/\/doi.org\/10.1002\/bimj.201500263. Epub 2017\/02\/01.","journal-title":"Biom J"},{"issue":"2","key":"21313_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11906-020-1017-9","volume":"22","author":"CC Nwabuo","year":"2020","unstructured":"Nwabuo CC, Vasan RS. Pathophysiology of Hypertensive Heart Disease: Beyond Left Ventricular Hypertrophy. Curr Hypertens Rep. 2020;22(2):11. https:\/\/doi.org\/10.1007\/s11906-020-1017-9. Epub 2020\/02\/06.","journal-title":"Curr Hypertens Rep"},{"issue":"20","key":"21313_CR29","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","volume":"275","author":"D Levy","year":"1996","unstructured":"Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. JAMA. 1996;275(20):1557\u201362. Epub 1996\/05\/22. PubMed PMID: 8622246.","journal-title":"JAMA"},{"issue":"11","key":"21313_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993\u20131004. https:\/\/doi.org\/10.1056\/NEJMoa1409077. Epub 2014\/09\/02.","journal-title":"N Engl J Med"},{"issue":"4","key":"21313_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ccl.2010.07.005","volume":"28","author":"VV Georgiopoulou","year":"2010","unstructured":"Georgiopoulou VV, Kalogeropoulos AP, Raggi P, Butler J. Prevention, diagnosis, and treatment of hypertensive heart disease. Cardiol Clin. 2010;28(4):675\u201391. PubMed PMID: 20937450.","journal-title":"Cardiol Clin"},{"issue":"2","key":"21313_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global Burden of Hypertension and systolic blood pressure of at least 110 to 115\u00a0mm hg, 1990\u20132015. JAMA. 2017;317(2):165\u201382. https:\/\/doi.org\/10.1001\/jama.2016.19043. Epub 2017\/01\/18.","journal-title":"JAMA"},{"issue":"9","key":"21313_CR33","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1097\/hjh.0000000000001006","volume":"34","author":"I Maatouk","year":"2016","unstructured":"Maatouk I, Herzog W, B\u00f6hlen F, Quinzler R, L\u00f6we B, Saum KU, et al. Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults. J Hypertens. 2016;34(9):1711\u201320. https:\/\/doi.org\/10.1097\/hjh.0000000000001006. Epub 2016\/06\/25.","journal-title":"J Hypertens"},{"key":"21313_CR34","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neubiorev.2021.08.031","volume":"131","author":"LF Lim","year":"2021","unstructured":"Lim LF, Solmi M, Cortese S. Association between anxiety and hypertension in adults: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2021;131:96\u2013119. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.08.031. Epub 2021\/09\/06.","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"21313_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1001\/jama.2013.184182","volume":"310","author":"CK Chow","year":"2013","unstructured":"Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310(9):959\u201368. https:\/\/doi.org\/10.1001\/jama.2013.184182. Epub 2013\/09\/05.","journal-title":"JAMA"},{"issue":"30","key":"21313_CR36","first-page":"649","volume":"48","author":"Decline in","year":"1999","unstructured":"Decline in. Deaths from heart disease and stroke\u2013United States, 1900\u20131999. MMWR Morb Mortal Wkly Rep. 1999;48(30):649\u201356. Epub 1999\/09\/17. PubMed PMID: 10488780.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"8","key":"21313_CR37","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1001\/jama.282.8.724","volume":"282","author":"From the Centers for Disease Control and Prevention","year":"1999","unstructured":"From the Centers for Disease Control and Prevention. Decline in deaths from heart disease and stroke\u2013United States, 1900\u20131999. JAMA. 1999;282(8):724\u20136. Epub 1999\/08\/27. PubMed PMID: 10463697.","journal-title":"JAMA"},{"issue":"7","key":"21313_CR38","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/circresaha.121.318083","volume":"128","author":"RM Carey","year":"2021","unstructured":"Carey RM, Wright JT Jr., Taler SJ, Whelton PK. Guideline-Driven Management of Hypertension: an evidence-based update. Circ Res. 2021;128(7):827\u201346. https:\/\/doi.org\/10.1161\/circresaha.121.318083. Epub 2021\/04\/02.","journal-title":"Circ Res"},{"issue":"4","key":"21313_CR39","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1016\/s2214-109x(20)30078-4","volume":"8","author":"M Levy","year":"2020","unstructured":"Levy M, Chen Y, Clarke R, Bennett D, Tan Y, Guo Y, et al. Socioeconomic differences in health-care use and outcomes for stroke and ischaemic heart disease in China during 2009-16: a prospective cohort study of 0\u00b75 million adults. Lancet Glob Health. 2020;8(4):e591\u2013602. https:\/\/doi.org\/10.1016\/s2214-109x(20)30078-4. Epub 2020\/03\/22.","journal-title":"Lancet Glob Health"},{"issue":"10112","key":"21313_CR40","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/s0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390(10112):2549\u201358. https:\/\/doi.org\/10.1016\/s0140-6736(17)32478-9. Epub 2017\/11\/06.","journal-title":"Lancet"},{"issue":"1","key":"21313_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12199-017-0634-7","volume":"22","author":"Y Shen","year":"2017","unstructured":"Shen Y, Chang C, Zhang J, Jiang Y, Ni B, Wang Y. Prevalence and risk factors associated with hypertension and prehypertension in a working population at high altitude in China: a cross-sectional study. Environ Health Prev Med. 2017;22(1):19. https:\/\/doi.org\/10.1186\/s12199-017-0634-7. Epub 2017\/11\/23.","journal-title":"Environ Health Prev Med"},{"issue":"23","key":"21313_CR42","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.jacc.2020.04.038","volume":"75","author":"C Wang","year":"2020","unstructured":"Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, et al. Association of Age of Onset of Hypertension with Cardiovascular diseases and Mortality. J Am Coll Cardiol. 2020;75(23):2921\u201330. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.038. Epub 2020\/06\/13.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"21313_CR43","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/hypertensionaha.107.107474","volume":"51","author":"E Gerdts","year":"2008","unstructured":"Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008;51(4):1109\u201314. https:\/\/doi.org\/10.1161\/hypertensionaha.107.107474. Epub 2008\/02\/09.","journal-title":"Hypertension"},{"key":"21313_CR44","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5978314","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang Y, Li K, Du K, Huang X, Zhou Z, et al. Retrospective study of aging and sex-specific risk factors of COVID-19 with hypertension in China. Cardiovasc Ther. 2022. https:\/\/doi.org\/10.1155\/2022\/5978314. 2022:5978314. Epub 2022\/07\/19.","journal-title":"Cardiovasc Ther"},{"issue":"6","key":"21313_CR45","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/circresaha.116.303587","volume":"116","author":"L Te Riet","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH. Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res. 2015;116(6):960\u201375. https:\/\/doi.org\/10.1161\/circresaha.116.303587. Epub 2015\/03\/15.","journal-title":"Circ Res"},{"issue":"5","key":"21313_CR46","doi-asserted-by":"publisher","first-page":"R459","DOI":"10.1152\/ajpregu.00222.2013","volume":"305","author":"B Xue","year":"2013","unstructured":"Xue B, Johnson AK, Hay M. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen. Am J Physiol Regul Integr Comp Physiol. 2013;305(5):R459\u201363. https:\/\/doi.org\/10.1152\/ajpregu.00222.2013. Epub 2013\/07\/26.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"21313_CR47","doi-asserted-by":"publisher","unstructured":"Sampson AK, Moritz KM, Jones ES, Flower RL, Widdop RE, Denton KM. Enhanced angiotensin II type 2 receptor mechanisms mediate decreases in arterial pressure attributable to chronic low-dose angiotensin II in female rats. Hypertension (Dallas, Tex: 1979). 2008;52(4):666\u201371. Epub 2008\/08\/20. https:\/\/doi.org\/10.1161\/hypertensionaha.108.114058. PubMed PMID: 18711010.","DOI":"10.1161\/hypertensionaha.108.114058"},{"issue":"2","key":"21313_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.7150\/ijms.13456","volume":"13","author":"J Liu","year":"2016","unstructured":"Liu J, Ma J, Wang J, Zeng DD, Song H, Wang L, et al. Comorbidity Analysis according to sex and age in hypertension patients in China. Int J Med Sci. 2016;13(2):99\u2013107. https:\/\/doi.org\/10.7150\/ijms.13456. Epub 2016\/03\/05.","journal-title":"Int J Med Sci"},{"key":"21313_CR49","doi-asserted-by":"publisher","unstructured":"Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J et al. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273\u2009\u2013\u200983. Epub 2018\/12\/07. https:\/\/doi.org\/10.1038\/s41440-018-0154-x. PubMed PMID: 30518984.","DOI":"10.1038\/s41440-018-0154-x"},{"issue":"7","key":"21313_CR50","first-page":"483","volume":"108","author":"S Tao","year":"1995","unstructured":"Tao S, Wu X, Duan X, Fang W, Hao J, Fan D, et al. Hypertension prevalence and status of awareness, treatment and control in China. Chin Med J. 1995;108(7):483\u20139. Epub 1995\/07\/01. PubMed PMID: 7555263.","journal-title":"Chin Med J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-21313-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-21313-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T10:14:42Z","timestamp":1739182482000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-21313-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21313"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-21313-6","relation":{"references":[{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"},{"id-type":"uri","id":"","asserted-by":"subject"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"24 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The informed consent was waived because no identifying data were used.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"534"}}